摘要
目的:分析1例乳腺癌患者术后使用帕妥珠单抗注射液联合注射用曲妥珠单抗辅助治疗出现4级腹泻后的用药情况。方法:临床药师参与1例乳腺癌患者术后使用帕妥珠单抗注射液联合注射用曲妥珠单抗辅助治疗出现4级腹泻的临床治疗,协助医生制定止泻方案,并对患者进行药学监护。结果:临床药师参与后,成功控制了患者的4级腹泻。结论:临床药师通过参与乳腺癌患者术后使用帕妥珠单抗注射液联合注射用曲妥珠单抗辅助治疗所致4级腹泻的临床治疗,提供个体化用药方案,发挥了积极作用。
Objective:To analyze the use of pertuzumab injection combined with trastuzumab injection for adjuvant treatment of grade 4 diarrhea in a patient with breast cancer after surgery.Methods:Clinical pharmacists participated in the clinical treatment of grade 4 diarrhea in a breast cancer patient after surgery with pertuzumab injection combined with trastuzumab for injection,assisted doctors in developing antidiarrheal programs,and conducted pharmaceutical care for the patient.Results:With the participation of clinical pharmacists,Grade 4 diarrhea was successfully controlled.Conclusion:Clinical pharmacists have played a positive role in the clinical treatment of grade 4 diarrhea caused by postoperative pertuzumab injection combined with trastuzumab for injection,providing individualized medication plan for breast cancer patients.
作者
梁紫微
吕丹丹
LIANG Ziwei;Lv Dandan(Department of Pharmacy,Anshun People’s Hosp ital,Anshun Guizhou 561000;Department of Oncology,Anshun People’s Hosp ital,Anshun Guizhou 561000)
